{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T13:39:04Z","timestamp":1795268344479,"version":"4.10.3"},"reference-count":77,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"crossref","award":["724016003"],"award-info":[{"award-number":["724016003"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["310913"],"award-info":[{"award-number":["310913"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2021,12,29]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) has the characteristics of high-density desmoplastic stroma, a distinctive immunosuppressive microenvironment and is profoundly resistant to all forms of chemotherapy and immunotherapy, leading to a 5-year survival rate of 9%. Our study aims to add novel small molecule therapeutics for the treatment of PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We have studied whether TAK-981, a novel highly selective and potent small molecule inhibitor of the small ubiquitin like modifier (SUMO) activating enzyme E1 could be used to treat a preclinical syngeneic PDAC mouse model and we have studied the mode of action of TAK-981.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that SUMOylation, a reversible post-translational modification required for cell cycle progression, is increased in PDAC patient samples compared with normal pancreatic tissue. TAK-981 decreased SUMOylation in PDAC cells at the nanomolar range, thereby causing a G2\/M cell cycle arrest, mitotic failure and chromosomal segregation defects. TAK-981 efficiently limited tumour burden in the KPC3 syngeneic mouse model without evidence of systemic toxicity. In vivo treatment with TAK-981 enhanced the proportions of activated CD8 T cells and natural killer (NK) cells but transiently decreased B cell numbers in tumour, peripheral blood, spleen and lymph nodes. Single cell RNA sequencing revealed activation of the interferon response on TAK-981 treatment in lymphocytes including T, B and NK cells. TAK-981 treatment of CD8 T cells ex vivo induced activation of STAT1 and interferon target genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings indicate that pharmacological inhibition of the SUMO pathway represents a potential strategy to target PDAC via a dual mechanism: inhibiting cancer cell cycle progression and activating anti-tumour immunity by inducing interferon signalling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2021-324834","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T13:21:25Z","timestamp":1643030485000},"page":"2266-2283","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":134,"title":["Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model"],"prefix":"10.1136","volume":"71","clinical-trial-number":[{"clinical-trial-number":"nct04381650","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04776018","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04074330","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03648372","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04065555","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0102-0567","authenticated-orcid":false,"given":"Sumit","family":"Kumar","sequence":"first","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J A","family":"Schoonderwoerd","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie S","family":"Kroonen","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona J","family":"de Graaf","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Sluijter","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ruano","sequence":"additional","affiliation":[{"name":"Pathology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1n","family":"Gonz\u00e1lez-Prieto","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matty","family":"Verlaan-de Vries","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Rip","sequence":"additional","affiliation":[{"name":"Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Arens","sequence":"additional","affiliation":[{"name":"Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel F C C","family":"de Miranda","sequence":"additional","affiliation":[{"name":"Pathology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-9325","authenticated-orcid":false,"given":"Lukas J A C","family":"Hawinkels","sequence":"additional","affiliation":[{"name":"Gastroenterology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9115-558X","authenticated-orcid":false,"given":"Thorbald","family":"van Hall","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-0493","authenticated-orcid":false,"given":"Alfred C O","family":"Vertegaal","sequence":"additional","affiliation":[{"name":"Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"2025112110032209000_71.11.2266.1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1166"},{"key":"2025112110032209000_71.11.2266.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"2025112110032209000_71.11.2266.3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57131"},{"key":"2025112110032209000_71.11.2266.4","doi-asserted-by":"publisher","DOI":"10.1101\/gad.275776.115"},{"key":"2025112110032209000_71.11.2266.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.06.003"},{"key":"2025112110032209000_71.11.2266.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59227"},{"key":"2025112110032209000_71.11.2266.7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3723"},{"key":"2025112110032209000_71.11.2266.8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4123"},{"key":"2025112110032209000_71.11.2266.9","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0027"},{"key":"2025112110032209000_71.11.2266.10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.010"},{"key":"2025112110032209000_71.11.2266.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200694"},{"key":"2025112110032209000_71.11.2266.12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40425-016-0119-z","article-title":"From bench to bedside a comprehensive review of pancreatic cancer immunotherapy","volume":"4","author":"Kunk","year":"2016","journal-title":"j. immunotherapy cancer"},{"key":"2025112110032209000_71.11.2266.13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5306\/wjco.v8.i3.230","article-title":"Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations","volume":"8","author":"Guo","year":"2017","journal-title":"World J Clin Oncol"},{"key":"2025112110032209000_71.11.2266.14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-306271"},{"key":"2025112110032209000_71.11.2266.15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312078"},{"key":"2025112110032209000_71.11.2266.16","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3011"},{"key":"2025112110032209000_71.11.2266.17","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2293"},{"key":"2025112110032209000_71.11.2266.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00630-X"},{"key":"2025112110032209000_71.11.2266.19","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.135.6.1457"},{"key":"2025112110032209000_71.11.2266.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(03)00141-2"},{"key":"2025112110032209000_71.11.2266.21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.embor738"},{"key":"2025112110032209000_71.11.2266.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.02.006"},{"key":"2025112110032209000_71.11.2266.23","doi-asserted-by":"publisher","DOI":"10.1038\/nature07963"},{"key":"2025112110032209000_71.11.2266.24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3342"},{"key":"2025112110032209000_71.11.2266.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802114115"},{"key":"2025112110032209000_71.11.2266.26","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.81"},{"key":"2025112110032209000_71.11.2266.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.09.006"},{"key":"2025112110032209000_71.11.2266.28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208210"},{"key":"2025112110032209000_71.11.2266.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.02.007"},{"key":"2025112110032209000_71.11.2266.30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-015-0164-y","article-title":"Knockdown of SUMO-activating enzyme subunit 2 (Sae2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer","volume":"8","author":"Liu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"2025112110032209000_71.11.2266.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123882","article-title":"Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"2025112110032209000_71.11.2266.32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/bjc.2013.531","article-title":"PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells","volume":"109","author":"Chien","year":"2013","journal-title":"Br J Cancer"},{"key":"2025112110032209000_71.11.2266.33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1212728"},{"key":"2025112110032209000_71.11.2266.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-584524"},{"key":"2025112110032209000_71.11.2266.35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.319"},{"key":"2025112110032209000_71.11.2266.36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1415569112"},{"key":"2025112110032209000_71.11.2266.37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41416-020-01119-6","article-title":"The SUMO pathway in pancreatic cancer: insights and inhibition","volume":"124","author":"Schneeweis","year":"2021","journal-title":"Br J Cancer"},{"key":"2025112110032209000_71.11.2266.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317856"},{"key":"2025112110032209000_71.11.2266.39","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01491"},{"key":"2025112110032209000_71.11.2266.40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO signaling to Wrestle cancer","volume":"7","author":"Kroonen","year":"2021","journal-title":"Trends in Cancer"},{"key":"2025112110032209000_71.11.2266.41","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2463"},{"key":"2025112110032209000_71.11.2266.42","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geq052"},{"key":"2025112110032209000_71.11.2266.43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11773-x","article-title":"The poly-SUMO2\/3 protease SENP6 enables assembly of the constitutive centromere-associated network by group deSUMOylation","volume":"10","author":"Liebelt","year":"2019","journal-title":"Nat Commun"},{"key":"2025112110032209000_71.11.2266.44","doi-asserted-by":"publisher","DOI":"10.2174\/138920312802430563"},{"key":"2025112110032209000_71.11.2266.45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03486-4","article-title":"Sumo targets the APC\/C to regulate transition from metaphase to anaphase","volume":"9","author":"Eifler","year":"2018","journal-title":"Nat Commun"},{"key":"2025112110032209000_71.11.2266.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2005.10.007"},{"key":"2025112110032209000_71.11.2266.47","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1080\/15384101.2016.1191713","article-title":"Sumo-Interacting motifs (SIMs) in polo-like kinase 1-interacting checkpoint helicase (PICH) ensure proper chromosome segregation during mitosis","volume":"15","author":"Sridharan","year":"2016","journal-title":"Cell Cycle"},{"key":"2025112110032209000_71.11.2266.48","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6358-4_13"},{"key":"2025112110032209000_71.11.2266.49","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.136"},{"key":"2025112110032209000_71.11.2266.50","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3901"},{"key":"2025112110032209000_71.11.2266.51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw937"},{"key":"2025112110032209000_71.11.2266.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.04.023"},{"key":"2025112110032209000_71.11.2266.53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.10.6477"},{"key":"2025112110032209000_71.11.2266.54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-369736"},{"key":"2025112110032209000_71.11.2266.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.04.003"},{"key":"2025112110032209000_71.11.2266.56","first-page":"2312","article-title":"Small ubiquitin-like modifier alters IFN response","volume":"195","author":"Maarifi","year":"2015","journal-title":"J.i."},{"key":"2025112110032209000_71.11.2266.57","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00236-9"},{"key":"2025112110032209000_71.11.2266.58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1182\/blood.V89.2.583","article-title":"Bone marrow and thymus expression of interferon-\u03b3 results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies","volume":"89","author":"Young","year":"1997","journal-title":"Blood"},{"key":"2025112110032209000_71.11.2266.59","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0710"},{"key":"2025112110032209000_71.11.2266.60","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0349"},{"key":"2025112110032209000_71.11.2266.61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12939","article-title":"Regulatory B cells in cancer","volume":"299","author":"Michaud","year":"2021","journal-title":"Immunol Rev"},{"key":"2025112110032209000_71.11.2266.62","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.143"},{"key":"2025112110032209000_71.11.2266.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00412-006-0079-z"},{"key":"2025112110032209000_71.11.2266.64","doi-asserted-by":"publisher","DOI":"10.1038\/373078a0"},{"key":"2025112110032209000_71.11.2266.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.10.021"},{"key":"2025112110032209000_71.11.2266.66","doi-asserted-by":"publisher","DOI":"10.1021\/pr401258d"},{"key":"2025112110032209000_71.11.2266.67","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201438534"},{"key":"2025112110032209000_71.11.2266.68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba7791","article-title":"A small-molecule sumoylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models","volume":"13","author":"Lightcap","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025112110032209000_71.11.2266.69","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz430"},{"key":"2025112110032209000_71.11.2266.70","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030590"},{"key":"2025112110032209000_71.11.2266.71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2288"},{"key":"2025112110032209000_71.11.2266.72","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"2025112110032209000_71.11.2266.73","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2025112110032209000_71.11.2266.74","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0433-8"},{"key":"2025112110032209000_71.11.2266.75","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"2025112110032209000_71.11.2266.76","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303"},{"key":"2025112110032209000_71.11.2266.77","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1106"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2021-324834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:03:31Z","timestamp":1763748211000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2021-324834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":77,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/gutjnl-2021-324834"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2021-324834","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}